Free Trial

Benchmark's Rating of Aeluma on 9/24/2025

On September 24, 2025, Benchmark updated its outlook on Aeluma (NASDAQ:ALMU) with the action "Reiterated Rating", keeping a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Benchmark Co.

DateCompanyAction
9/29/2025
Wingstop Inc. stock logo
WING
Wingstop
Lower Price Target
9/26/2025
Live Nation Entertainment, Inc. stock logo
LYV
Live Nation Entertainment
Boost Price Target
9/25/2025
Saia, Inc. stock logo
SAIA
Saia
Reiterated Rating
9/24/2025
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Boost Price Target
9/24/2025
Sandisk Corporation stock logo
SNDK
Sandisk
Boost Price Target
9/24/2025
Aeluma, Inc. stock logo
ALMU
Aeluma
Reiterated Rating
More Ratings From Benchmark Co.